Startups
A pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases.
Overview
Employees
1-10
Total raised
$25M
Founded date
2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 10, 2021 | Harrow Health : Q2-2021 Letter to Stockholders | Harrow Health, Inc. Letter to Stockholders August 10, 2021 To the Stockholders of Harrow Health, Inc.: Harrow continues to be a reliable and innovative pharmaceutical supplier to hundreds of thousands of Americans and many thousands of eyec... |
| Jul 25, 2021 | Surface Ophthalmics Raises $25M in Funding | Surface Ophthalmics, a Pleasanton CA-based pharmaceutical company, raised $25M in funding. Investors included both new and existing investors made up of institutional, healthcare-focused, and other accredited investors, including members of... |
| Jul 21, 2021 | Harrow Health : Proceeds from the capital raise will help to support and advance Surface's ongoing clinical programs in ocular diseases (Form 8-K) | Proceeds from the capital raise will help to support and advance Surface's ongoing clinical programs in ocular diseases PLEASANTON, California, 21 July 2021 - Surface Ophthalmics, Inc., a pharmaceutical company focused on the development an... |
| Jul 21, 2021 | Surface Ophthalmics Announces $25 Million Private Round of Fundraising | PLEASANTON, Calif., July 21, 2021 /PRNewswire/ -- Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced it has secured gross proc... |
| Jul 21, 2021 | Surface Ophthalmics Announces $25 Million Private Round of Fundraising | |
| Mar 31, 2021 | Surface Ophthalmics Announces Preeya K. Gupta, MD as Chief Medical Advisor | |
| Jan 21, 2021 | Surface Ophthalmics Announces Positive Top-Line Results from Phase II Trial for SURF-201 (Betamethasone 0.2% in Klarity® vehicle) for the Treatment of Post-Cataract Surgery Pain and Inflammation |
Reviews 0
FAQ about Surface Ophthalmics, Inc.
When was Surface Ophthalmics, Inc. founded?
Surface Ophthalmics, Inc. was founded in 2018.
How much funding has Surface Ophthalmics, Inc. raised?
Surface Ophthalmics, Inc. has raised $25M in total across 1 funding round.
What has the press written about Surface Ophthalmics, Inc.?
Parsers VC has collected 8 articles mentioning Surface Ophthalmics, Inc., among them “Harrow Health : Q2-2021 Letter to Stockholders” (Aug 10, 2021) and “Surface Ophthalmics Raises $25M in Funding” (Jul 25, 2021).
Is Surface Ophthalmics, Inc. still active?
Yes, Surface Ophthalmics, Inc. is active; its latest activity on Parsers VC dates from Nov 10, 2021.